Excellent Neil, I still like the recommendation I gave you on SEELOS Therapeutics.
Ketamine is very much still under the radar for most US investors. It's a very strong med and Johnson&Johnson's strangle hold on the scripts will come to an end. I'm watching for $2.90-$3.40 and will probably buy back in. I've made 4 round trips on it in the last 2 months for over $20K in profits. big gainer ;)
patient trials are due in April/May.
my only concern with a buy & hold strategy is a secondary raise, even though they just did one... pharmas love to grab money when it's sitting on the table.... ramping up for commercialization is pricey
This will be trading $5-$10 soon enough. either before or after data on patient trials
** for others, sorry to post on here, I can't send Private Messages